| (KRW) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 467.25B | — |
| Operating expense | — | — |
| Net income | 83.31B | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, 128940.KS returned +47.4% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -7.7% |
| 1 year | +47.4% |
| 5 years | +87.9% |
| 10 years | +13.8% |
| All-time high | ₩633,338 (Nov 2015) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what ₩1,000 in 128940.KS would be worth today ›Yes. Hanmi Pharm. Co., Ltd. paid 1 dividend over the past 12 months. The most recent was ₩2,000 per share on Mar 30, 2026. The dividend yield is 0.48%.
Hanmi Pharm. Co., Ltd. is part of the Healthcare sector.
Hanmi Pharm. Co., Ltd. has a market cap of 6.85T KRW, based on the latest quote.
Hanmi Pharm. Co., Ltd. is expected to report earnings around Oct 29, 2026. That date is an estimate and has not been confirmed by the company.
